Table 2 Baseline characteristics of the 1398 patients with available QL data

From: Quantifying trade-offs: quality of life and quality-adjusted survival in a randomised trial of chemotherapy in postmenopausal patients with lymph node-negative breast cancer

 

Tam

CMF → Tam

Total

Total eligible cases

701 (100)

697 (100)

1398 (100)

ER-negative

147 (21)

149 (21)

296 (21)

ER-positive

525 (75)

516 (74)

1041 (74)

ER-unknown

29 (4)

32 (5)

61 (4)

Total mastectomy

332 (47)

350 (50)

682 (49)

Breast conservation

369 (53)

347 (50)

716 (51)

 With planned RT

322 (87)

313 (90)

635 (89)

 Without planned RT

47 (13)

34 (10)

81 (11)

Tumour size1.0 cm

78 (11)

84 (12)

162 (12)

Tumour size 1.1–2.0 cm

336 (48)

335 (48)

671 (48)

Tumour size>2.0 cm

262 (37)

252 (36)

514 (37)

Tumour size unknown

25 (4)

26 (4)

51 (4)

Tumour grade 1

131 (19)

123 (18)

254 (18)

Tumour grade 2

294 (42)

285 (41)

579 (41)

Tumour grade 3

234 (33)

242 (35)

476 (34)

Tumour grade unknown

42 (6)

47 (7)

89 (6)

Vessel invasion absent

540 (77)

528 (76)

1068 (76)

Vessel invasion present

147 (21)

151 (22)

298 (21)

Vessel invasion not examined

14 (2)

18 (2)

32 (2)

Age (median [range])

61 [34–78]

60 [44–81]

61 [34–81]